'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC
'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC
'醫療保險現在可以覆蓋Eli Lilly的Zepbound用於睡眠呼吸暫停，康哲藥業表示' - CNBC
Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC.
That opens the door for broader coverage of and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss specifically.
Medicare Part D plans can cover obesity drugs if they are used for an additional medically accepted purpose approved by the Food and Drug Administration.
醫療保險藥物計劃現在可以覆蓋艾 Eli Lilly 的重磅減肥藥物 Zepbound 用於阻塞性睡眠 apnea，醫療保險和醫療補助服務中心向 CNBC 確認。
這爲更廣泛的覆蓋和獲取 Zepbound 打開了大門，Zepbound 目前未被醫療保險和許多其他保險計劃爲減肥特別覆蓋。
如果醫療保險部分 D 計劃用於獲得食品與藥物管理局批准的額外醫學認可的用途，則可覆蓋減肥藥。
Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on...
醫療保險藥物計劃現在可以覆蓋艾 Eli ...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。